| Comunicación Nº: 090 | English version  |
| Comunicación Nº: 090 | English version |
Antonio Cremades Mira, Esther Roselló Sastre, M. Angeles González, Rafael Ferrer, AuroraVillanueva.
[Título] [Introducción] [Material y Métodos] [Resultados] [Discusión]
|
|
1.- DeLellis RA. Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features. Lab Invest 1995; 72: 494-505.
2.- Rosai J, Carcangiu ML, DeLellis RA. Medullary carcinoma. In: Rosai J, editor. Atlas of Tumor Pathology. Tumors of the Thyroid Gland. Third Series. Vol. 5. Washington, D.C.: AFIP, 1992; 207-245.
3.- Guarda LA, Peterson CE, Hall W, Baskin HJ. Anaplastic thyroid carcinoma: Cytomorphology and clinical implications of fine-needle aspiration. Diagn Cytopathol 1991; 7:63-67.
4.- Chen KTK. Fine-needle aspiration cytology of papillary Hürthle-cell tumors of thyroid: A report of three cases. Diagn Cytopathol 1991; 7: 53-56.
5- Kaur A, Jayaram G. Thyroid tumors: Cytomorphology of papillary carcinoma. Diagn Cytopathol 1991; 7: 462-468.
6.- Bisi H, Asato de Camargo RY, Filho AL. Role of fine-needle aspiration cytology in the management of thyroid nodules: Review of experience with 1,925 cases. Diagn Cytopathol 1992; 8: 504-510.
7.- Harach HR, Zusman SB, Day ES. Nodular goiter: A histo-cytological study with some emphasis on pitfalls of fine-needle aspiration cytology. Diagn Cytopathol 1992; 8: 409-419.
8.- Viale G, Roncalli M, Grimelius L, Graziani D, Wilander E, Johansson H, Bergholm U, Coggi G. Prognostic value of Bcl-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol 1995; 26: 945-950.
9.- Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer 1997; 79: 564-573.
|
